A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF6001

NCT02386761 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Single Ascending Dose (SAD)
DRUG: Multiple Ascending Dose (MAD)

Sponsor

Chiesi Farmaceutici S.p.A.